company background image
I8S logo

Intrasense DB:I8S Stock Report

Last Price

€0.30

Market Cap

€14.4m

7D

5.6%

1Y

-25.2%

Updated

21 Nov, 2024

Data

Company Financials

I8S Stock Overview

Intrasense SA designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. More details

I8S fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Intrasense S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Intrasense
Historical stock prices
Current Share Price€0.30
52 Week High€0.45
52 Week Low€0.20
Beta-0.84
11 Month Change8.70%
3 Month Change7.14%
1 Year Change-25.19%
33 Year Change-51.61%
5 Year Change22.70%
Change since IPO-10.71%

Recent News & Updates

Recent updates

Shareholder Returns

I8SDE Healthcare ServicesDE Market
7D5.6%-0.6%-1.3%
1Y-25.2%-33.0%7.4%

Return vs Industry: I8S exceeded the German Healthcare Services industry which returned -33.1% over the past year.

Return vs Market: I8S underperformed the German Market which returned 7.1% over the past year.

Price Volatility

Is I8S's price volatile compared to industry and market?
I8S volatility
I8S Average Weekly Movement18.8%
Healthcare Services Industry Average Movement5.9%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: I8S's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: I8S's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
200474Alexandre Salvadorwww.intrasense.fr

Intrasense SA designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. The company offers Myrian Imaging Layer, a multimodal visualization software platform suite for health industrials; Myrian Studio, a solution for the development of medical imaging applications for innovators, industrial clients, spin-offs, and research labs; and Myrian technologies to develop biomarkers and artificial intelligence solutions. It also provides Myrian Clinical Apps, a portfolio of clinical applications for advanced post-processing, which include Myrian XP-Breast; Myrian XP-Prostate; Myrian XP-Liver; Myrian XP-Mammo; Myrian XP-Lung; Myrian XP-Colon; Myrian XL-Onco, a lesion tracking solutions; Myrian XP-Vessel; Myrian XP-Cardiac; solution for pathology or organ; and various tools for the analysis of MRI, CT, conventional, radiology, and nuclear imaging exams.

Intrasense S.A. Fundamentals Summary

How do Intrasense's earnings and revenue compare to its market cap?
I8S fundamental statistics
Market cap€14.40m
Earnings (TTM)-€3.89m
Revenue (TTM)€2.33m

6.2x

P/S Ratio

-3.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
I8S income statement (TTM)
Revenue€2.33m
Cost of Revenue€3.78m
Gross Profit-€1.45m
Other Expenses€2.44m
Earnings-€3.89m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.074
Gross Margin-62.06%
Net Profit Margin-166.91%
Debt/Equity Ratio17.1%

How did I8S perform over the long term?

See historical performance and comparison